Molecular biology of cytokines

被引:35
作者
Dendorfer, U
机构
关键词
cytokines; interleukin-6; transcriptional regulation; transcription factors; NF-kappa B;
D O I
10.1111/j.1525-1594.1996.tb04529.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The development of the technological armamentarium of molecular biology has revolutionized biomedical research in general and nephrologic investigation in particular. In addition to the recent identification of several genes involved in normal kidney function and pathologic conditions, our knowledge regarding the role of cytokines in primary renal diseases, transplant rejection, and dialysis effects has expanded greatly. In particular, molecular biologic methodology has provided insight into the mechanisms controlling cytokine gene regulation, which occurs primarily at the transcriptional level and is mediated by DNA-binding proteins interacting with specific recognition motifs in genetic promoter and enhancer elements. Interleukin-6 (IL-6) is discussed as an example because it is a secretory product of mesangial cells and participates in the cytokine network that determines glomerular and interstitial inflammation. In our analysis of IL-6 gene regulation employing reporter gene and electrophoretic mobility shift assays, we have found that bacterial lipopolysaccharide and cyclic adenosine monophosphate synergistically induce IL-6 expression in macrophages through at least four transcription factors, including AP-1, cAMP-responsive element-binding protein (CREB), NF-IL6, and NF-kappa B. One of the most exciting areas of future research will focus on transcription factor activation in experimental and clinical disease states. Novel therapeutic approaches targeting transcriptional regulation are currently being explored.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 90 条
[51]  
OSAWA H, 1995, NEPHROL DIAL TRANSPL, V10, P1592
[52]   TRANSCRIPTION FACTORS [J].
PAPAVASSILIOU, AG .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (01) :45-47
[53]  
PAULEUGENE N, 1992, J IMMUNOL, V149, P3066
[54]   TRANSCRIPTION FACTOR BASED THERAPEUTICS - DRUGS OF THE FUTURE [J].
PETERSON, MG ;
BAICHWAL, VR .
TRENDS IN BIOTECHNOLOGY, 1993, 11 (01) :11-17
[55]   A NEW VIEW OF PROSTAGLANDIN-E REGULATION OF THE IMMUNE-RESPONSE [J].
PHIPPS, RP ;
STEIN, SH ;
ROPER, RL .
IMMUNOLOGY TODAY, 1991, 12 (10) :349-352
[56]   INTERLEUKIN-6 PRODUCTION BY TUMOR-NECROSIS-FACTOR AND LIPOPOLYSACCHARIDE-STIMULATED RAT RENAL-CELLS [J].
PIROTZKY, E ;
DELATTRE, RM ;
HELLEGOUARCH, A ;
LONCHAMPT, MO ;
AARDEN, L ;
BRAQUET, P ;
GALANAUD, P .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 56 (02) :271-279
[57]   LOCAL PRODUCTION OF INTERLEUKIN-6 DURING ACUTE REJECTION IN HUMAN RENAL-ALLOGRAFTS [J].
RAASVELD, MHM ;
WEENING, JJ ;
KERST, JM ;
SURACHNO, S ;
TENBERGE, RJM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (01) :75-78
[58]  
RADEKE HH, 1992, CLIN INVESTIGATOR, V70, P825
[59]   ACTIVATION OF THE HUMAN BETA-2-INTERFERON HEPATOCYTE-STIMULATING FACTOR INTERLEUKIN-6 PROMOTER BY CYTOKINES, VIRUSES, AND 2ND MESSENGER AGONISTS [J].
RAY, A ;
TATTER, SB ;
MAY, LT ;
SEHGAL, PB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6701-6705
[60]   A MULTIPLE CYTOKINE-RESPONSIVE AND 2ND MESSENGER-RESPONSIVE ELEMENT IN THE ENHANCER OF THE HUMAN INTERLEUKIN-6 GENE - SIMILARITIES WITH C-FOS GENE-REGULATION [J].
RAY, A ;
SASSONECORSI, P ;
SEHGAL, PB .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (12) :5537-5547